Dopamine receptors in GtoPdb v.2023.1
Jean‐Martin Beaulieu(University of Toronto), Hubert H.M. Van Tol(University of Toronto), Marc G. Caron(Duke University), Maria Cristina Missale(Brescia University), David K. Grandy(Oregon Health & Science University), Raul R. Gainetdinov(St Petersburg University), Pierre Sokoloff(Inserm), Gilberto Fisone(Karolinska Institutet), Stefano Espinoza(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Saloman Z. Langer(Compugen (Israel)), Kim A. Neve(Oregon Health & Science University), Olivier Civelli(University of California, Irvine), B. Scatton(Sanofi (Turkey)), David R. Sibley(National Institutes of Health), Emiliana Borrelli(University of Calabria), Pierre F. Spano(University of Brescia), Jean‐Charles Schwartz(Inserm), Arvid Carlsson(Chalmers University of Technology), John W. Kebabian(National Institute of Neurological Disorders and Stroke), Göran Sedvall(Karolinska Institutet), Philip Seeman(University of Toronto)
Cited by 3
Related Papers
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
|Pharmacological Reviews|2011|2.7k
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
|Nature|1991|2k
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor
|Science|1995|1.8k
Cloning and expression of a rat D2 dopamine receptor cDNA
|Nature|1988|1.1k
Multiple dopamine D4 receptor variants in the human population
|Nature|1992|967